$HGEN News Article - Humanigen Announces First Participant Dosed in RATinG Trial of Lenzilumab for Early Treatment of Acute Graft Versus Host Disease Following Allogeneic Stem Cell Transplantation
https://marketwirenews.com/news-releases/huma...56306.html